Abstract
Aromatization of testosterone to estradiol was investigated in a human prostatic carcinoma cell line, LNCaP. A saturable, dose and time-dependent aromatization of testosterone was observed. Kinetic parameters, K(m) (201 nM) and V(max) (0.76 pmol/h per mg) and also the inhibition constants (K(i)) for various aromatase inhibitors were calculated from standard Lineweaver-Burke plots. The steroidal aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione (4-OHA) and its derivative, 4-methoxy-4-androstene-3,17-dione (4-OMA), inhibited aromatization of testosterone in a competitive pattern of inhibition. The derivative 4-OMA is the stronger inhibitor of the two, with an apparent K(i) of 1.12 μM, whereas the apparent K(i) of 4-OHA is 3.28 μM. Long term incubation with 4-OMA suppressed proliferative activity of LNCaP cells in the presence of physiological levels of testosterone (10-10 M to 10-7 M). In contrast, 4-OHA was a growth promoter. These results suggest a potential role for aromatase in hormone responsive prostate cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 143-148 |
Number of pages | 6 |
Journal | Cancer Letters |
Volume | 101 |
Issue number | 2 |
DOIs | |
State | Published - Mar 29 1996 |
Externally published | Yes |
Keywords
- Androgens
- Aromatase
- Growth suppression
- Prostate cancer
ASJC Scopus subject areas
- Oncology
- Cancer Research